Stemline Therapeutics, Inc.
(NASDAQ : STML)

( )
STML PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading STML News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.81%70.660.9%$747.87m
AMGNAmgen Inc.
-1.62%170.851.1%$707.06m
CELGCelgene Corporation
-2.18%130.931.1%$645.79m
REGNRegeneron Pharmaceuticals, Inc.
-2.67%502.122.7%$590.62m
BIIBBiogen Inc.
-3.06%271.251.2%$491.73m
ALXNAlexion Pharmaceuticals, Inc.
-2.38%122.111.9%$450.82m
VRTXVertex Pharmaceuticals Incorporated
-3.13%129.231.9%$271.19m
INCYIncyte Corporation
-3.24%130.312.6%$256.98m
CLVSClovis Oncology, Inc.
-4.76%89.9618.0%$244.46m
TSROTESARO, Inc.
-3.87%141.0314.7%$243.48m
BLUEBluebird Bio, Inc.
-3.78%106.9019.3%$159.98m
ILMNIllumina, Inc.
-2.50%176.363.5%$150.43m
KITEKite Pharma, Inc.
-2.37%98.0516.1%$139.68m
EXASExact Sciences Corporation
-2.43%34.0926.3%$128.59m
AAgilent Technologies, Inc.
-0.63%58.871.5%$122.37m

Company Profile

Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, acquisition, development, and commercialization of novel therapeutics for oncology indications of unmet medical need. It develops a discovery platform called StemScreen, which identifies novel compounds that target and kill cancer stem cells. The company was founded by Ivan Bergstein on August 8, 2003 and is headquartered in New York, NY.,009QKB-E